# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-17-002784
Filing Date
2017-05-08
Accepted
2017-05-08 15:02:04
Documents
45
Period of Report
2017-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 10-Q | f10q_050817p.htm | 10-Q | 560198
2 | EXHIBIT 31.1 | exh_311.htm | EX-31.1 | 9455
3 | EXHIBIT 31.2 | exh_312.htm | EX-31.2 | 9440
4 | EXHIBIT 32.1 | exh_321.htm | EX-32.1 | 3592
5 | EXHIBIT 32.2 | exh_322.htm | EX-32.2 | 3450
| Complete submission text file | 0001171843-17-002784.txt |  | 3927525

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL INSTANCE FILE | bcrx-20170331.xml | EX-101.INS | 714156
7 | XBRL SCHEMA FILE | bcrx-20170331.xsd | EX-101.SCH | 48439
8 | XBRL CALCULATION FILE | bcrx-20170331_cal.xml | EX-101.CAL | 37469
9 | XBRL DEFINITION FILE | bcrx-20170331_def.xml | EX-101.DEF | 345216
10 | XBRL LABEL FILE | bcrx-20170331_lab.xml | EX-101.LAB | 321417
11 | XBRL PRESENTATION FILE | bcrx-20170331_pre.xml | EX-101.PRE | 349475

Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23186 | Film No.: 17821891
SIC: 2836 Biological Products, (No Diagnostic Substances)